Plain-English translation of NCT06825013 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our COPD research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing Breztri™ Aerosphere©, a combination inhaler that delivers three medications together to treat COPD. The study wants to understand whether this particular inhaler design helps medication reach the smallest airways in your lungs better than other inhalers, and whether that improvement actually helps you feel less short of breath when you exercise and do daily activities.
People with COPD often struggle to breathe during exercise because the small airways in their lungs don't work well, even with treatment. This medication is designed to target those small airways more effectively, but researchers need to prove whether that actually helps patients feel and perform better.
You likely qualify if…
You likely don't qualify if…
You will visit the research center for exercise testing sessions where you breathe into specialized equipment while exercising on a stationary bike or treadmill. In a crossover design, you'll receive the study medication during one visit and a placebo (salt water) during another visit, with your lungs' function and your breathing comfort measured during exercise both times. The study will help researchers understand whether this inhaler design truly improves how your lungs work during activity.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
Canada